Skip to main content

ACTR8 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-82551

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-82551-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of Human ACTR8. Peptide sequence: MTQAEKGDTENGKEKGGEKEKEQRGVKRPIVPALVPESLQEQIQSNFIIV The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for ACTR8 Antibody

Western Blot: ACTR8 Antibody [NBP2-82551]

Western Blot: ACTR8 Antibody [NBP2-82551]

Western Blot: ACTR8 Antibody [NBP2-82551] - Host: Rabbit. Target Name: ACTR8. Sample Type: Jurkat Whole Cell lysates. Antibody Dilution: 1.0ug/ml

Applications for ACTR8 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: ACTR8

Alternate Names

Actin-Related Protein 8, ARP8, ARP8 (Actin-Related Protein 8, Yeast) Homolog, ARP8 Actin-Related Protein 8 Homolog, HArp8, INO80 Complex Subunit N, INO80N

Gene Symbol

ACTR8

Additional ACTR8 Products

Product Documents for ACTR8 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ACTR8 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...